35 results
6-K
ENLV
Enlivex Therapeutics Ltd
15 Jun 20
Report of Foreign Private Issuer
6:55am
is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7): ☐
Remote Access to Annual and Extraordinary General Meeting … :
https://us02web.zoom.us/j/84302881164
Or access via telephone:
US: +1 929 436 2866 or +1 669 900 6833
South Korea: +82 (0) 2 6022 2322
Hong Kong
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
12 Sep 22
Report of Foreign Private Issuer
8:02am
and latest advances in oncology; and (3) promote equal access to optimal cancer care for all patients.
ABOUT ALLOCETRA™
Allocetra™ is being developed
424B5
ENLV
Enlivex Therapeutics Ltd
18 Mar 16
Prospectus supplement for primary offering
12:00am
will not provide further significant data. Patients will be offered access to the drug in an expanded access program.
In March, 2016, we announced final … electronically with the SEC, which you can access over the Internet athttp://www.sec.gov.You may also access the information we file electronically with the SEC
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
19 Feb 19
Asset Purchase Agreement
4:57pm
.
Access. During the period commencing on the date hereof and continuing through the Closing Date, Seller shall (a) afford to Buyer and its officers … , directors, employees, accountants, counsel and other employees or representatives reasonable access to all of Seller’s properties, books, contracts
6-K
EX-99.1
w3swukifr 79bmvv0m
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.1
9d6ft2xo
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.1
jcupq2
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-1.1
ymiytjb leydlcy48qqi
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-1.1
23esw9d y1onx6yr1s
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-10.1
92uqr8nhwx98
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-99.1
hjyj6byn
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-10.1
3c1fz sc52x609i48ca
30 Dec 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-99.2
06jh5
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
20-F/A
b08q95 861
23 Jan 20
Annual report (foreign) (amended)
4:31pm